TRACON Pharmaceuticals, Inc. (TCON) Financials

TCON Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 10.1 million 10.9 million
2023-09-30 9.4 million 12.5 million
2023-06-30 12.2 million 27.9 million
2023-03-31 8.3 million 19.4 million

TCON Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -522000 490000
2023-09-30 15.1 million 493000
2023-06-30 -5.9 million 502000
2023-03-31 -5.0 million 484000

TCON Net Income

No data available :(

TCON Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 8.6 million - 236000
2023-09-30 7.8 million - -
2023-06-30 1.7 million - -
2023-03-31 6.6 million - -

TCON Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 40.2 million
2023-09-30 36.9 million
2023-06-30 30.8 million
2023-03-31 23.7 million

TCON Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 1.5 million 1.1 million -
2023-09-30 - 2.3 million 1.3 million -
2023-06-30 - 3.5 million 1.9 million -
2023-03-31 - 5.0 million 2.3 million -

TCON Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 3.0 million 3000
2023-09-30 - 4000
2023-06-30 9.0 million 3000
2023-03-31 - 4000

TCON

Price: $1.85

52 week price:
1.71
41.00

Earnings Per Share: -2.20 USD

P/E Ratio: -0.45

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 47100

Ebitda: 1.4 million

Market Capitalization: 5.4 million

Links: